Genetic Interaction Analysis via Molecular Network Refining
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current gene screening methods, particularly those using CRISPR and RNAi, face significant challenges with false positives due to off-target effects and multiple testing issues, leading to inconsistent identification of cancer-essential genes and suppressor genes across studies.
Innovation Solution
A method that excludes loss-of-function data from non-expressed genes and refines genetic interactions using molecular networks like KEGG and PPI networks to derive synthetic partner networks, reducing false positives and improving precision in identifying genetic interactions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If CRISPR and RNAi techniques are used for high-throughput loss-of-function screening to identify genetic interactions, then the productivity of gene screening is improved, but the reliability of results deteriorates due to considerable false positives from off-target effects and multiple testing issues
Solution Approach 1:
The method performs preliminary filtering by excluding non-expressed genes before conducting genetic interaction analysis. This preliminary action removes genes that cannot produce functional effects, thereby reducing the search space and eliminating a source of false positives before the main screening process begins
Solution Approach 2:
The patent introduces molecular networks (KEGG pathways and protein-protein interaction networks) as intermediary structures to validate genetic interaction results. These networks serve as a reference framework to distinguish true biological interactions from false positives, mediating between the screening results and final validation
2Quantity of substance
If loss-of-function data from all genes including non-expressed genes is analyzed, then the quantity of data available for analysis is increased, but the precision of genetic interaction characterization deteriorates due to inclusion of irrelevant data from non-expressed genes
Solution Approach 1:
The method extracts and removes non-expressed genes from the loss-of-function data set before analysis. By taking out these irrelevant data points, the method concentrates on only the expressed genes that can actually influence cellular phenotypes, thereby improving the precision of genetic interaction characterization without significantly compromising the quantity of meaningful data
3Ease of operation
If genetic interactions are characterized without considering molecular network context, then the ease of operation is improved, but the reliability of results worsens due to inability to distinguish true interactions from false positives
Solution Approach 1:
The method performs preliminary mapping of genes to molecular networks (KEGG pathways and PPI networks) before conducting the genetic interaction analysis. This preliminary organization of genes into their biological context frameworks enables subsequent validation steps to be performed systematically, maintaining reliability without excessive complexity
Solution Approach 2:
The patent implements a feedback mechanism where molecular network information is used to validate and refine genetic interaction results. The network context provides feedback on whether identified interactions are biologically plausible, allowing the method to distinguish true interactions from false positives while maintaining operational feasibility
Data Source
AI summary
Disclosed herein are a method for analyzing a genetic interaction to reduce a false positive in gene screening for at least one gene cluster associated with at least one type of cells by deriving the genetic interaction and a synthetic partner with at least one profile selected from the group consisting of a mutation profile, a loss-of-function profile, and an expression profile; and a system using same.